Chlorhexidine (Cx) augmented with beta-cyclodextrin (β-cd) inclusion compounds, termed Cx:β-cd complexes, have been developed for use as antiseptic agents. The aim of this study was to examine the interactions of Cx:β-cd complexes, prepared at different molecular ratios, with sterol and yeast membranes. 
INTRODUCTION
Chlorhexidine (Cx) is an effective chemical antiseptic that has a bactericidal effect at high concentrations (2-5%) and a bacteriostatic effect at low concentrations (0.6%). The antimicrobial activity of Cx is thought to be due to bacterial membrane disruption, which leads to increased cell permeability and leakage of intracellular ions (Na Cyclodextrin inhibits yeast growth 36, 37) . Agents containing high concentrations of Cx have been used in periodontic and endodontic clinical practice. Cx has also been safely used at very low concentrations in several commercial products for dental hygiene, including mouthwashes, gels, and sprays. However the transitory effects of Cx have been shown to have deleterious effects on cells in vitro (15, 17, 40) .
Cyclodextrins have been used as tools to manipulate the lipid composition of biological and model membranes (29) .
Their hydrophilic outer surface and hydrophobic inner core enable them to form inclusion complexes by trapping small amphiphilic molecules in their core. Beta-cyclodextrins (β-cds)
are particularly efficient sterol acceptors, apparently because the size of their inner hydrophobic cavity matches the size of the sterol molecule (18, 28, 30, 34) . Indeed, Cholesterol can be removed from cells by extraction into small unilamellar vesicles of β-cds (5, 6, 7).
Hence, in order to reduce the toxicity caused by high concentrations of Cx, chlorhexidine:beta-cyclodextrin (Cx:β-cd) complexes have been developed for use as antiseptic agents. These complexes offer advantages in effectiveness, long-term activity, and antimicrobial efficacy at low concentrations (10) . Their key component, β-cd, creates regions of hydrophobic cavity that surround Cx. Gels containing Cx:β-cd complexes were shown to exhibit higher antimicrobial activity against oral microorganismal pathogens than non-augmented Cx in a long-term in vitro study (10) .
However, previous studies characterizing Cx activity provide little information regarding the mechanisms underlying microorganism-drug interactions on a nanometer scale.
Understanding the structure and properties of microbial surfaces at the nanometer level is of great importance for the development of novel antimicrobial compounds. Cx inclusion complexes and biological membranes are limited, these complexes have attracted interest in many fields, as they could be used to release biologically-active drugs through membrane contact in diverse tissues (35) .
The aim of this study was to investigate the anti-fungal activity of Cx inclusion complexes comprised of different Cx:β-cd molar ratios and to characterize the interactions of these complexes with yeast membranes using a C.a. strain as an experimental model. 
MATERIALS AND METHODS

Chemicals and yeast stocks
Preparation of supramolecular complexes
Cx:β-cd inclusion complexes were prepared by freezedrying aqueous solutions of β-cd and Cx at different relative molar ratios (Cx:β-cd: 1:1, 1:2, 1:3, and 1:4) as described elsewhere (9) .
Antimicrobial assay
Yeast cultures were grown and maintained in Sabouraud were used as standard antimicrobial positive controls and β-cd was used as a negative control (8).
Sample absorbance was measured using a standard spectrophotometer (Spectrumlamb 22PC ® ) set to 580 nm, and sample data were analyzed and compared to controls. Six replicates were analyzed for each condition, and MIC values were recorded and evaluated using the non-parametric KruskalWallis test. P-values less than 0.05 were considered significant.
Yeast viability assay
The concentration of cells in a 0.5 µg/mL suspension was determined using a standard hemocytometer. The yeast suspension was diluted 100-fold with sterile water. Cells were then diluted in an equal volume of 0.4% trypan blue to assess the number of viable cells. Total cell counts were also performed with a hemocytometer. Calculations involving cell populations were based on viable cell counts (33) .
Sterol Quantification Method (SQM)
Total intracellular sterols were extracted using the SQM described by Arthington-Skaggs et al. (3) 
RESULTS
Antifungal activity
The MIC 90 data are summarized in Table 1 showed that treatment with Cx alone or with the inclusion compounds, particularly Cx:β-cd 1:3 and 1:4, led to significant reductions in ergosterol levels (Fig. 1) . Membrane leakage increased progressively as cells were exposed to greater concentrations of β-cd (1:1, 1:2 vs. 1:3 or 1:4, P <0.05). 
SEM analysis of Cx:β-cd complex interactions with membranes
SEM revealed crystalline structures in some regions of the membranes that were exposed to Cx (see micrograph in Fig.   2A ). The β-cd alone control molecules (Fig. 2B ) produced a semi-crystalline structure. However, the addition of β-cd molecules appeared to disrupt the crystalline character of the Cx structures. That is, with increasing ratios of β-cd in the Cx:β-cd complexes from 1:1 to 1:4 ( Fig. 2C-F) -and therefore increasing concentration of β-cd being delivered to the cellular membranes-the membrane-associated Cx molecules appeared to lose their regular crystalline appearance, becoming increasingly amorphous (Fig. 3C-D) .
C.a. cells treated with Cx and Cx:β-cd complexes were also analyzed by SEM; untreated C.a. cells served as controls to assess normal yeast membrane morphology (Fig. 3A) . In the Cx alone treatment group, Cx molecules surrounded the yeast cells, binding the membranes only at singular points (Fig. 3B ).
Structures resembling Cx were visualized around the yeast cellular membrane, generally near one or two break points in the membrane. Initial morphological changes in Cx-treated cells included the appearance of indentations on the surface of some cells as well as the presence of micelle-like structures and membrane residues near the cells (Fig. 3C-D) .
The membranes of C.a. cells treated with Cx:β-cd complexes (1:1, 1:2, 1:3, and 1:4 ratios) showed slight differences in the size and shape of the liquid-ordered domain relative to membranes exposed to Cx alone (Fig. 3C-F) , and showed various leakage points in the membrane structure that
were not seen in Cx-exposed membranes (Fig. 3B) . Exposure of C.a. to Cx:β-cd complexes at a concentration of 1 μg/mL led to dramatic changes in membrane structure. In these samples, the C.a. membrane domains and inclusion compounds coalesced into larger, less rounded domains ( Fig. 3E-F) .
Additionally, the cells appeared to lose their characteristic shape and to allow leakage of intracellular substances (Fig. 3 C-F) (11, 20, 38) . In general, membrane surfaces are strongly affected by the ability of the aqueous structures to form hydrogen bonds (24, 38) . Hydrophilic membrane structure-disrupting cyclodextrins can enhance drug delivery by increasing the concentration gradient of a drug and favoring more rapid drug delivery to the membrane surface.
In this study, we found that sterol extraction increased with rising concentrations of β-cd in the Cx:β-cd complex solutions. Hence, since membrane lipid composition has the potential to modulate membrane fusogenic capacity, it may also affect susceptibility to pathogens (31).
In conclusion, the experiments reported here demonstrated that β-cd has an important effect on the interaction between Cx and C.a. cells. We showed for the first time that β-cd facilitates the interaction between Cx and the yeast cell membrane by enhancing the molecular affinity of Cx for the membrane, wherein Cx:β-cd complexes form nanoaggregate clusters within the yeast cell membrane. We further showed that these Cx:β-cd nanoaggregates inhibit yeast growth by extracting ergosterol and thereby permeabilizing the yeast cell membrane.
Finally, this permeabilization effect appears to enhance the antifungal efficacy of Cx.
